Engineered Binding Proteins that Specifically Target Bacteria
Exclusively Licensed
Invention type: Technology
/
Case number: #22368
Described herein are antigen-binding molecules that bind to bacteria (e.g., Listeria monocytogenes) and methods of use thereof. Also described herein are compositions and kits comprising these antigen-binding molecules.
Researchers
Hadley Sikes
/
Yining Hao
/
Ki-Joo Sung
Departments: Department of Chemical Engineering
Technology Areas: Biotechnology: Biomanufacturing, DNA & RNA Editing, Synthetic Biology / Therapeutics: Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
engineered binding proteins for recognition of bacteria
European Patent Convention | Published application -
engineered binding proteins for recognition of bacteria
Mexico | Published application -
engineered binding proteins for recognition of bacteria
Japan | Published application -
engineered binding proteins for recognition of bacteria
Singapore | Pending -
engineered binding proteins for recognition of bacteria
United States of America | Published application
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.